Manufacturer record

Pharma Force Lab (Unit-II): regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Pharma Force Lab (Unit-II) (Himachal Pradesh) were declared Not of Standard Quality between February 2022 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Pharma Force Lab (Unit-II) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2022 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2022
2
Products affected
Assay
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2022 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Montelukast & Levocetirizine Dihydrochloride E9AIY029Mfg 2025-08 · Exp 2027-07 Assay of Montelukast Sodium IP & Levocetirizine Dihydrochloride IPAssay FDTL,UttarakhandState lab Feb 2026
Sucralfate and Oxetacaine Oral Suspension (1g, 20mg/10ml) (SUCRAMAL-O SUSPENSION) P2AWU002Mfg 2021-06 · Exp 2023-05 Assay of OxetacaineAssay RDTL ChandigarhState lab Feb 2022
Sucralfate and Oxetacaine Oral Suspension (1g, 20mg/10 ml) (SUCRAMAL- O SUSPENSION ) P2AWU001Mfg 2021-06 · Exp 2023-05 Assay of OxetacaineAssay RDTL ChandigarhState lab Feb 2022

Batches reported as suspected spurious under this label

CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.

ProductBatchReported byFirm's replyAlert
L-Carnitine, L- Tartarate ,Mecobalamin & Folic Acid TabletsB95Y032SDTL, AssamThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Apr 2026
Trypsin-Chymotrypsin Tablets2KU6L055FDAL MaharashtraThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Jan 2026
Deflazacort Tablets 6 mg Defcort 613240334ARDTL, ChandigarhThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Dec 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.